LACEY ANDERSON: Open Payments
NPI 1346639267 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 18 payments from 9 companies in 2025. Trend: 2023 $148 · 2024 $59 · 2025 $425
Food & beverage: $372Education: $53
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $141 |
| Smith+Nephew, Inc. | 2 | $75 |
| SANOFI-AVENTIS U.S. LLC | 1 | $53 |
| GENZYME CORPORATION | 2 | $44 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Cochlear Americas | 1 | $21 |
| Hologic Sales and Service, LLC | 1 | $19 |
| Integra LifeSciences Corporation | 1 | $16 |
Products named: NUCALA, DUPIXENT, GRAFIX PL, HALO, COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE, CoolSeal Generator, ACCLARENT AERA.
Industry payments across KS — which companies pay providers there.
